3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Buy
56
BMRN Quote, Financials, Valuation and Earnings
Last price:
$58.85
Seasonality move
:
3.2%
Day range:
$58.81 - $60.66
52-week range:
$52.93 - $94.85
Dividend yield:
0%
P/E ratio:
21.88x
P/S ratio:
3.94x
P/B ratio:
1.95x
Volume:
1M
Avg. volume:
1.9M
1-year change:
-27.97%
Market cap:
$11.3B
Revenue:
$2.9B
EPS (TTM):
$2.69
Biomarin Pharmaceutical SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical
|
04/26/2024 | 10-Q | 10-Q filing on 04/26/2024 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/26/2024 | 10-K | 10-K filing on 02/26/2024 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/02/2023 | 10-Q | 10-Q filing on 11/02/2023 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/02/2023 | 10-Q | 10-Q filing on 08/02/2023 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
04/28/2023 | 10-Q | 10-Q filing on 04/28/2023 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/27/2023 | 10-K | 10-K filing on 02/27/2023 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
10/28/2022 | 10-Q | 10-Q filing on 10/28/2022 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
04/29/2022 | 10-Q | 10-Q filing on 04/29/2022 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/25/2022 | 10-K | 10-K filing on 02/25/2022 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
10/29/2021 | 10-Q | 10-Q filing on 10/29/2021 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
07/30/2021 | 10-Q | 10-Q filing on 07/30/2021 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
04/30/2021 | 10-Q | 10-Q filing on 04/30/2021 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/26/2021 | 10-K | 10-K filing on 02/26/2021 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/06/2020 | 10-Q | 10-Q filing on 11/06/2020 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/05/2020 | 10-Q | 10-Q filing on 08/05/2020 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
05/01/2020 | 10-Q | 10-Q filing on 05/01/2020 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/27/2020 | 10-K | 10-K filing on 02/27/2020 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/04/2019 | 10-Q | 10-Q filing on 11/04/2019 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
10/29/2019 | 10-Q | 10-Q filing on 10/29/2019 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/02/2019 | 10-Q | 10-Q filing on 08/02/2019 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/28/2019 | 10-K | 10-K filing on 02/28/2019 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
10/26/2018 | 10-Q | 10-Q filing on 10/26/2018 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/03/2018 | 10-Q | 10-Q filing on 08/03/2018 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
04/27/2018 | 10-Q | 10-Q filing on 04/27/2018 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/26/2018 | 10-K | 10-K filing on 02/26/2018 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/13/2017 | 10-Q | 10-Q filing on 11/13/2017 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
10/31/2017 | 10-Q | 10-Q filing on 10/31/2017 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/02/2017 | 10-Q | 10-Q filing on 08/02/2017 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
05/04/2017 | 10-Q | 10-Q filing on 05/04/2017 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/27/2017 | 10-K | 10-K filing on 02/27/2017 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
05/02/2016 | 10-Q | 10-Q filing on 05/02/2016 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
11/02/2015 | 10-Q | 10-Q filing on 11/02/2015 | View Form |
|
BMRN
Biomarin Pharmaceutical
|
08/05/2015 | 10-Q | 10-Q filing on 08/05/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
